Nuzenio

Oric Pharmaceuticals

Oric Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 22 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 11:39:26 GMTORIC Pharmaceuticals (ORIC) Q2 Losses Put Valuation In Focus As Shares Rally - simplywall.st
Sat, 08 Aug 2026 07:36:09 GMTDimensional Fund Advisors LP Boosts Holdings in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Sat, 08 Aug 2026 00:49:59 GMTPrice to book forward of Oric Pharmaceuticals, Inc. – SWB:4TZ - TradingView
Fri, 07 Aug 2026 20:30:00 GMTORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance Singapore
Wed, 05 Aug 2026 15:30:00 GMTEvercore ISI Keeps Their Buy Rating on Oric Pharmaceuticals (ORIC) - The Globe and Mail
Wed, 05 Aug 2026 13:00:00 GMTA Quick Look at Today's Ratings for Oric Pharmaceuticals(ORIC.US), With a Forecast Between $14 to $25 - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Oric Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.